Breast / Breasts / Cancer / Drugs

FDA OKs First Targeted Drug for HER2-Low Breast Cancer

Posted on: Aug 6, 2022   |   Posted by: Master Doctor

FDA OKs First Targeted Drug for HER2-Low Breast Cancer

The FDA has approved the first targeted therapy for unresectable/metastatic breast cancer in the newly defined low-HER2 subtype. The approval for trastuzumab deruxtecan...

Continue reading ...